SAN
DIEGO, Oct. 5, 2023 /PRNewswire/ -- Illumina,
Inc. (NASDAQ:ILMN) announced today that it will issue results for
the third quarter 2023 following the close of market on
Thursday, November 9, 2023.
On the same day, at 2:00 pm Pacific
Time (5:00 pm Eastern Time)
Jacob Thaysen, Chief Executive
Officer, and Joydeep Goswami, Chief
Financial Officer and Chief Strategy and Corporate Development
Officer, will host a conference call with analysts, investors, and
other interested parties to discuss financial and operating
results.
Conference Call Details
The conference call will begin at 2:00 pm
Pacific Time (5:00 pm Eastern
Time) on Thursday, November 9,
2023. Interested parties may access the live teleconference
through the Investor Info section of Illumina's website at
investor.illumina.com. Alternatively, individuals can access the
call by dialing 866.400.0049 or +1.323.794.2149 outside
North America, both with
Conference ID 1991305. To ensure timely connection, please dial in
at least ten minutes before the scheduled start of the call.
A replay of the conference call will be posted on
Illumina's website after the event and will be available for
at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the
genome. In 2023, we celebrate 25 years of innovation, which has
established us as a global leader in DNA sequencing and array-based
technologies, serving customers in the research, clinical and
applied markets. Our products are used for applications in the life
sciences, oncology, reproductive health, agriculture and other
emerging segments. To learn more, visit www.illumina.com and
connect with us on Twitter, Facebook, LinkedIn, Instagram, TikTok
and YouTube.
|
Investors:
|
|
Salli
Schwartz
|
|
+1.858.291.6421
|
|
ir@illumina.com
|
|
Media:
|
|
David
McAlpine
|
|
+1.347.327.1336
|
|
pr@illumina.com
|
View original
content:https://www.prnewswire.com/news-releases/illumina-to-announce-third-quarter-2023-financial-results-on-thursday-november-9-2023-301948912.html
SOURCE Illumina, Inc.